Please provide your email address to receive an email when new articles are posted on . Alopecia areata was classified as early-onset, severe or prolonged. Each additional atopic comorbidity raised ...

Early phototherapy initiation within one year of alopecia areata onset significantly improves hair regrowth outcomes, with disease duration being a key predictor of success. No significant difference ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Baricitinib maintained hair regrowth among adolescents ...

Hair loss caused by alopecia areata now has a new FDA-approved treatment, a third-in-class drug from Sun Pharmaceutical Industries that will compete against commercialized medicines from Eli Lilly and ...

Jerry Shapiro, MD, discusses strategies for treating patients with scarring and nonscarring alopecia.

A greater proportion of patients treated with deuruxolitinib 8mg achieved a SALT score of less than or equal to 20 (80% or more scalp hair) compared with placebo. The Food and Drug Administration (FDA ...

Asthma, atopic dermatitis or Hashimoto's thyroiditis as concomitant diseases are risk factors for clinical features associated with a poor prognosis in circular hair loss, also known as alopecia ...

Shaperon Introduces AI-Developed Alopecia Areata Drug Candidate. CAMBRIDGE, Mass & RESEARCH TRIANGLE PARK, N.C. & SEOUL, South Korea--(BUSINESS WIRE)--Hudson Therapeutics, a leading innovator in ...

The FDA approved the oral Janus kinase (JAK) inhibitor deuruxolitinib (Leqselvi) to treat alopecia areata, drugmaker Sun Pharmaceutical announced on Thursday. The approval stipulates use of ...

5 Things to Avoid When You Have Alopecia Areata Alopecia areata is an autoimmune disease in which the body attacks the hair follicles. If you’re one of the 6.8 million people in the U.S. with this ...

Dear Doctors: I am a healthy 23-year-old woman. I started noticing extra hairs in my brush, and then my mom found two bald spots on the back of my head. I did a telehealth appointment and they said it ...

Treatment with deuruxolitinib and ritlecitinib, two investigational Janus kinase (JAK) inhibitors, resulted in substantial regrowth of scalp hair for patients with alopecia areata (AA) in separate ...